Double Expression | List of Frontiers open access articles

Case Report

Published on 30 Apr 2019

Roles of Type 1 Insulin-Like Growth Factor (IGF) Receptor and IGF-II in Growth Regulation: Evidence From a Patient Carrying Both an 11p Paternal Duplication and 15q Deletion

in Pediatric Endocrinology

Eloïse Giabicani
Sandra Chantot-Bastaraud
Adeline Bonnard
Myriam Rachid
Sandra Whalen
Irène Netchine
Frédéric Brioude

Frontiers in Endocrinology

doi 10.3389/fendo.2019.00263

4,618 views
13 citations

Original Research

Published on 12 Mar 2025

Zanubrutinib plus R-CHOP improves the treatment effect of newly diagnosed diffuse large B cell lymphoma with double expression of MYC and BCL-2

in Cancer Immunity and Immunotherapy

Min Zhang
Yingying Wu
Zhipeng Cheng
Lu Zhang
Lin Liu
Fang Liu
Guohui Cui
Linghui Xia
Yu Hu
Heng Mei

Frontiers in Immunology

doi 10.3389/fimmu.2025.1526318

6,029 views
3 citations

Original Research

Published on 09 Dec 2021

Clinical Features and Prognostic Significance of NOTCH1 Mutations in Diffuse Large B-Cell Lymphoma

in Cancer Genetics

Zhongqi Li
Fang Yu
Wenle Ye
Liping Mao
Jiansong Huang
Yang Shao
Junrong Yan
Wenjuan Yu
Jie Jin
Jinghan Wang

Frontiers in Oncology

doi 10.3389/fonc.2021.746577

7,830 views
14 citations

Case Report

Published on 18 Jan 2023

Case report: Successful management of a refractory double-expressor diffuse large B-cell lymphoma patient under the guidance of in vitro high-throughput drug sensitivity test

in Hematologic Malignancies

Lijie Xing
Hui Wang
Dan Liu
Qiang He
Zengjun Li

Frontiers in Oncology

doi 10.3389/fonc.2022.1079890

4,259 views
1 citation

Original Research

Published on 23 Aug 2022

Molecular subtyping of CD5+ diffuse large B-cell lymphoma based on DNA-targeted sequencing and Lymph2Cx

in Hematologic Malignancies

Dongshen Ma
Yuhan Ma
Yuanyuan Ma
Jia Liu
Ying Gu
Nian Liu
Chenxi Xiang
Hui Liu
Wei Sang

Frontiers in Oncology

doi 10.3389/fonc.2022.941347

5,612 views
9 citations

Original Research

Published on 14 Nov 2016

Introduction of an N-Glycosylation Site into UDP-Glucuronosyltransferase 2B3 Alters Its Sensitivity to Cytochrome P450 3A1-Dependent Modulation

in Pharmacogenetics and Pharmacogenomics

Tatsuro Nakamura
Naho Yamaguchi
Yuu Miyauchi
Tomoki Takeda
Yasushi Yamazoe
Kiyoshi Nagata
Peter I. Mackenzie
Hideyuki Yamada
Yuji Ishii

Frontiers in Pharmacology

doi 10.3389/fphar.2016.00427

5,018 views
12 citations

Articles

Roles of Type 1 Insulin-Like Growth Factor (IGF) Receptor and IGF-II in Growth Regulation: Evidence From a Patient Carrying Both an 11p Paternal Duplication and 15q Deletion

Zanubrutinib plus R-CHOP improves the treatment effect of newly diagnosed diffuse large B cell lymphoma with double expression of MYC and BCL-2

Clinical Features and Prognostic Significance of NOTCH1 Mutations in Diffuse Large B-Cell Lymphoma

Case report: Successful management of a refractory double-expressor diffuse large B-cell lymphoma patient under the guidance of in vitro high-throughput drug sensitivity test

Molecular subtyping of CD5+ diffuse large B-cell lymphoma based on DNA-targeted sequencing and Lymph2Cx

Introduction of an N-Glycosylation Site into UDP-Glucuronosyltransferase 2B3 Alters Its Sensitivity to Cytochrome P450 3A1-Dependent Modulation